H.R. 3061
Referred to CommitteeMedicare Prescription Drug Price Negotiation Act of 2015
Latest Action
Referred to the Subcommittee on Health.
7/20/2015 • House
Summary
Medicare Prescription Drug Price Negotiation Act of 2015
Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug plan.
Introduced in House • 7/14/2015
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (34)
Party Breakdown
Sponsor
Cosponsors (33)
Bill Journey
Originated in the House
Introduced
July 14, 2015
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (4)
H.R. 3513
Prescription Drug Affordability Act of 2015
S. 2023
Prescription Drug Affordability Act of 2015
H.R. 242
Medicare Prescription Drug Price Negotiation Act of 2017
S. 31
Medicare Prescription Drug Price Negotiation Act of 2015